Table 4 Predictive factors of central LNM in the HT group
From: Lymph node metastasis of papillary thyroid carcinoma in the context of Hashimoto’s thyroiditis
Variables | Central lymph node metastasis | |||||
|---|---|---|---|---|---|---|
Univariate analysis | Multivariate analysis | |||||
OR | 95%CI | P | OR | 95%CI | P | |
Age, year (< 55 / ≥55) | 0.20 | 0.06–0.60 | < 0.01 | 0.17 | 0.05–0.55 | < 0.01 |
Sex (Male, Female) | 0.75 | 0.27–2.07 | 0.58 | |||
TSH, median (3.49< / ≥3.49, μIU/mL) | 0.81 | 0.42–1.53 | 0.51 | |||
TPO-Ab, median (184.15< / ≥184.15, IU/mL) | 0.81 | 0.42–1.53 | 0.51 | |||
Tg-Ab, median (284.2< / ≥284.2, IU/mL) | 1.11 | 0.59–2.12 | 0.74 | |||
Tumor size, mm (≤10 / > 10) | 2.62 | 1.34–5.15 | 0.01 | 2.69 | 1.32–5.49 | 0.01 |
Multifocality (No / Yes) | 2.02 | 1.00–4.08 | 0.05 | 1.96 | 0.92–4.17 | 0.08 |
Extrathyroidal extension (No / Yes) | 0.46 | 0.39–0.55 | 0.22 | |||